Intel’s 200-Billion-Dollar Bet Leaves Stock Reeling Despite Record Analyst Targets

Intel’s stunning 186% year-to-date surge has hit a wall, with the stock shedding nearly 12% in a single week to close Friday at €96.26. The sell-off underscores a growing disconnect between Wall Street’s most bullish forecasts and the harsh realities of the chipmaker’s foundry pivot — a $200 billion gamble that has yet to prove itself to the market.

HSBC and Stifel have raised their price targets sharply in recent days, pushing the top end of Street estimates to a record $200 from HSBC analyst Frank Lee. Stifel’s Ruben Roy lifted his target from $75 to $120, while Goldman Sachs initiated coverage in late June at $150 with a neutral rating. Yet the average analyst consensus tracked by MarketBeat stands at just $97.88 — a figure that, converted to euros, sits below the current share price and implies limited upside. The market appears to be voting with its feet, ignoring the upgrades and locking in profits from a rally that had made Intel one of the best-performing chip stocks of 2024.

Three distinct headwinds converged to spook investors. First, reports surfaced that Intel’s next-generation 18A manufacturing process will not reach profitable yields until late 2026 or even 2027 — later than many had hoped. Second, rival AMD overtook Intel in quarterly data-center revenue for the first time, a symbolic and financial blow. Third, a broader sector sell-off triggered by a Bank of America warning on AI froth and weak Samsung earnings dragged down the entire chip complex. The options market reflected the unease, with Cboe data showing sharply divided sentiment among traders.

At the heart of the turbulence is Intel’s foundry transformation. The company has pledged roughly $200 billion in global investment, more than half of it in the U.S., to build a contract manufacturing business capable of challenging Taiwan Semiconductor. But the first-quarter results laid bare the cost: foundry revenue of $5.421 billion produced an operating loss of $2.437 billion. External customers contributed a mere $174 million, much of that from a one-time accounting reclassification tied to Altera. JPMorgan recently flagged Intel as one of the most compelling short candidates on the market, arguing that the stock’s rally has already priced in a foundry success story that is years away from materializing.

Should investors sell immediately? Or is it worth buying Intel?

Not everyone is convinced the gamble will fail. Wells Fargo notes that Intel’s AI-ASIC business already generates more than $1 billion in annual revenue, while Citi sees a coming super-cycle in wafer-fab equipment spending that could reach $250 billion globally by 2028. If Intel can scale its capacity in time, it could capture a meaningful slice of that wave. The 18A process remains the key — technical progress is indisputable, but the clock is ticking on converting test runs into profitable mass production for outside clients.

Technicals tell the story of a stock caught between momentum and gravity. At €96.26, Intel trades 6.4% below its 50-day moving average of €102.83, yet still 76% above its 200-day average of €54.67. The relative strength index sits at 42.8 — not oversold, but far from the enthusiasm that pushed the shares to a 52-week high of €124.58 on June 30. The 52-week low of €16.69, set in early August last year, underscores the explosive range. Annualized volatility has climbed to roughly 92%, making Intel one of the most jittery names in the semiconductor space.

All eyes now turn to July 23, when Intel reports second-quarter earnings after the U.S. market close. Management has guided for revenue between $13.8 billion and $14.8 billion, with adjusted earnings per share of $0.20. The consensus analyst target of €88.30 — more than 8% below Friday’s close — suggests the Street expects little near-term upside, even if the numbers come in as forecast. The earnings call will be a critical test: can Intel’s leadership sell the narrative of a turnaround anchored by 18A progress and new foundry customers, or will the market’s growing skepticism deepen the correction?

For a stock that has quadrupled over the past twelve months, the margin for error is razor-thin. Intel’s foundry bet is the biggest industrial transformation in the industry’s history, but the gap between promise and profit remains wide. The July 23 report will either narrow that gap — or expose it.